Priscilla Merriam, MD

Medical Oncologist
Dana-Farber Cancer Institute

Clinical Director, Sarcoma Center
Senior Physician, Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School

Poster(s):

• (P 143) A PHASE 1 B LEAD-IN TO A RANDOMIZED PHASE 2 TRIAL OF LURBINECTEDIN PLUS DOXORUBICIN IN LEIOMYOSARCOMA (LMS): RESULTS FROM THE PHASE 1B SOFT-TISSUE SARCOMA (STS) LEAD-IN

• (P 214) EXPERIENCE OF MANAGEMENT FOR LOCALIZED PARATESTICULAR LIPOSARCOMA: A SINGLE INSTITUTION COHORT